Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffroy Andrieux

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Blood|June 17, 2020
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humansJohana Norona, Petya Apostolova, Dominik Schmidt, et al.
British Journal of Haematology|November 9, 2023
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workupSenthilkumar Ramamoorthy, Dirk Lebrecht, Denny Schanze, et al.
Nature Communications|April 5, 2020
Oncogenic Kras<sup>G12D</sup> causes myeloproliferation via NLRP3 inflammasome activationShaima'a Hamarsheh, Lena Osswald, Benedikt S Saller, et al.
Signal Transduction and Targeted Therapy|January 16, 2026
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterationsPhilipp Hafner, Steffen J Keller, Xun Chen, et al.
Blood Advances|March 26, 2025
Hematological phenotypes in GATA2 deficiency syndrome arise from aging, maladaptation to proliferation, and somatic eventsJuncal Fernandez-Orth, Cansu Koyunlar, Julia Miriam Weiss, et al.
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Cancer Research|June 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow MicroenvironmentDominik Schmidt, Cornelia Endres, Rouven Hoefflin, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
The Lancet. Haematology|January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 studyJonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
The Journal of Experimental Medicine|September 29, 2023
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapyRomina Marone, Emmanuelle Landmann, Anna Devaux, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Blood|June 17, 2020
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humansJohana Norona, Petya Apostolova, Dominik Schmidt, et al.
British Journal of Haematology|November 9, 2023
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workupSenthilkumar Ramamoorthy, Dirk Lebrecht, Denny Schanze, et al.
Nature Communications|April 5, 2020
Oncogenic Kras<sup>G12D</sup> causes myeloproliferation via NLRP3 inflammasome activationShaima'a Hamarsheh, Lena Osswald, Benedikt S Saller, et al.
Signal Transduction and Targeted Therapy|January 16, 2026
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterationsPhilipp Hafner, Steffen J Keller, Xun Chen, et al.
Blood Advances|March 26, 2025
Hematological phenotypes in GATA2 deficiency syndrome arise from aging, maladaptation to proliferation, and somatic eventsJuncal Fernandez-Orth, Cansu Koyunlar, Julia Miriam Weiss, et al.
Blood Advances|March 31, 2025
AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signalingAlexander Zähringer, Inês Morgado, Daniel Erny, et al.
Cancer Research|June 17, 2024
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow MicroenvironmentDominik Schmidt, Cornelia Endres, Rouven Hoefflin, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
The Lancet. Haematology|January 17, 2026
Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 studyJonas S Heitmann, Yacine Maringer, Susanne Jung, et al.
The Journal of Experimental Medicine|September 29, 2023
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapyRomina Marone, Emmanuelle Landmann, Anna Devaux, et al.
Pageof 12